We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.17%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$353B
AUM Growth
+$72.1B
Cap. Flow
+$24.6B
Cap. Flow %
6.99%
Top 10 Hldgs %
35.85%
Holding
11,253
New
1,597
Increased
4,071
Reduced
4,134
Closed
1,264

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$869M
2
AAPL icon
Apple
AAPL
+$693M
3
PPLI
People Inc
PPLI
+$488M
4
EXPE icon
Expedia Group
EXPE
+$409M
5
CHTR icon
Charter Communications
CHTR
+$370M

Sector Composition

Rank Sector Weight
1 Technology 2.96%
2 Healthcare 2.64%
3 Financials 2.22%
4 Consumer Discretionary 2.1%
5 Industrials 1.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLY icon
9326
CALL
Valley National Bancorp
VLY
$8.23B
$69K ﹤0.01%
+10,100
New +$75K
GHSI
9327
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$69K ﹤0.01%
1,141
+1,025
+884% +$106K
ARA
9328
DELISTED
American Renal Associates Holdings, Inc
ARA
$69K ﹤0.01%
+10,079
New +$66.2K
AMRX icon
9329
PUT
Amneal Pharmaceuticals
AMRX
$5.9B
$68K ﹤0.01%
17,600
-50,900
-74% -$218K
KZR
9330
DELISTED
Kezar Life Sciences
KZR
$68K ﹤0.01%
1,415
-335
-19% -$16K
ACOR
9331
DELISTED
Acorda Therapeutics
ACOR
$68K ﹤0.01%
1,106
+967
+696% +$72.9K
AHT
9332
CALL
Ashford Hospitality Trust
AHT
$20.7M
$67K ﹤0.01%
+405
New +$152K
BEDU
9333
DELISTED
Bright Scholar Education Holdings
BEDU
$67K ﹤0.01%
+2,614
New +$78.1K
CPRX
9334
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$67K ﹤0.01%
22,400
+2,700
+14% +$10.6K
LITS
9335
PUT
Lite Strategy Inc
LITS
$32.1M
$67K ﹤0.01%
+1,080
New +$65.1K
PSEC icon
9336
Prospect Capital
PSEC
$1.13B
$67K ﹤0.01%
13,266
RYAM icon
9337
CALL
Rayonier Advanced Materials
RYAM
$591M
$67K ﹤0.01%
+20,800
New +$67.1K
TNXP icon
9338
Tonix Pharmaceuticals
TNXP
$179M
-1
Closed -$606K
UEC icon
9339
CALL
Uranium Energy
UEC
$5.2B
$67K ﹤0.01%
66,900
+5,000
+8% +$5.14K
YRD
9340
Yiren Digital
YRD
$101M
$67K ﹤0.01%
+22,673
New +$78.5K
MARK
9341
PUT
DELISTED
Remark Holdings, Inc.
MARK
$67K ﹤0.01%
5,690
+1,540
+37% +$21.4K
MBAI
9342
Check-Cap
MBAI
$8.89M
$66K ﹤0.01%
+9,098
New +$89.6K
DRRX
9343
CALL
DELISTED
DURECT Corp
DRRX
$66K ﹤0.01%
3,870
-1,470
-28% -$29.5K
EOLS icon
9344
Evolus
EOLS
$403M
$66K ﹤0.01%
+16,798
New +$61.4K
IBIO icon
9345
PUT
iBio
IBIO
$72.5M
$66K ﹤0.01%
+65
New +$94.2K
PTEN icon
9346
CALL
Patterson-UTI
PTEN
$3.83B
$66K ﹤0.01%
23,200
+8,600
+59% +$31.6K
SNCR
9347
PUT
DELISTED
Synchronoss Technologies
SNCR
$66K ﹤0.01%
2,422
-53,578
-96% -$1.78M
TBLT
9348
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$66K ﹤0.01%
+10
New +$68.6K
IDEX
9349
PUT
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$66K ﹤0.01%
582
-278
-32% -$44.2K
IMV
9350
PUT
DELISTED
IMV Inc. Common Shares
IMV
$66K ﹤0.01%
+1,480
New +$66.5K

Similar funds

Citadel Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Citadel Advisors held 11,253 positions worth $353B, up 26% from $280B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors deployed $24.6B of net new capital in Q3 2020, opening 1,597 new positions and adding to 4,071 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.3% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Amazon, an estimated $869M trimmed.

  • Citadel Advisors's largest Q3 2020 buy was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $1.04B increase.
  • Citadel Advisors's biggest Q3 2020 reduction was Amazon, cutting an estimated $869M.
  • Citadel Advisors fully exited Intel in Q3 2020, selling an estimated $249M.
  • Citadel Advisors's ten largest holdings make up 36% of its $353B portfolio in Q3 2020.
  • Citadel Advisors opened 1,597 new positions and closed 1,264 in Q3 2020.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $353B.

Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.